NYSE News: NYSE 100, NYSE 250, and NYSE 400 investment news
NYSE market news from the New York Stock Exchange

Latest NYSE News:

  • Oil, solar sectors gain on record crude prices

  • Microsoft up 9.2 percent on quarterly results

  • New home sales numbers don’t help Wall Street

  • Dow loses over 130 points by midday

  • Merck profits up 62 percent in third quarter

  • Quarterly reports disappoint Wall Street

  • Wall Street lower on banking sector

  • Wall Street mixed to end session

  • Home builders decline on comments, news

  • Citigroup lower on quarterly report

  • NYSE news feed


    Recommended equities news sites

  • NYSE
  • NasDaq
  • Dow Jones
  • Finance & Money
  • Eurofirst News
  • Tokyo Market News
  • FTSE News
  •  

    October 22, 2007

    Merck profits up 62 percent in third quarter

    Filed under: DR Horton, Toll Brothers, Administaff, Pulte Homes, Pfizer, Lennar, Merck, Hovnavian, Schering-Plough, Beazer Homes

    Wall Street was up in early afternoon trade on Monday after declines earlier in the day.

    The Dow Jones Industrial Average added 0.17 percent to 13,545.43, while the Nasdaq Composite gained 0.81 percent to 2,747.17 and the the S&P 500 was 0.23 percent higher to 1,504.04.

    In the pharmaceuticals sector, Merck (NYSE: MRK) added $1.21 to $54.32 after it reported that profits were up by 62 percent in the third quarter, boosted by ales of asthma and allergy drugs, blood pressure medicines, cholesterol drugs and a number of vaccines, including one for the prevention of cervical cancer.

    The only bad news was that the drug maker still faces liability over its Vioxx anti-inflammatory drug which was taken off the market after being implicated in cardiovascular events in patients who took it.

    Elsewhere in the sector, Schering-Plough (NYSE: SGP) dropped $4.29 to $28.42 after turning in a quarterly report that was not up to investors’ expectations.

    Meanwhile Pfizer (NYSE: PFE) was 3 cents lower to $24.04.

    Home builders were doing well in early afternoon trade, with several builders recording gains in the near-7 percent to nearly 8.5 percent range.

    Beazer Homes (NYSE: BZH) was up 76 cents to $9.82, while DR Horton (NYSE: DHI) was 88 cents higher to $12.83 and Hovnanian Enterprises (NYSE: HOV) had gained 89 cents to $11.44.

    Pulte Homes (NYSE: PHM) added 94 cents to $14.62 and Lennar (NYSE: LEN) was up $1.39 to $21.08, while Toll Brothers (NYSE: TOL) jumped $1.56 to $22.08.





    October 18, 2007

    Wall Street lower on banking sector

    Filed under: Administaff, Pfizer, Citigroup, Bank of America, Wells Fargo, JP Morgan, Wachovia, Washington Mutual, Hershey Co

    Wall Street was lower in early afternoon trade on Thursday after Bank of America (NYSE: BAC; TYO: 8648) reported that profits were down by 32 percent in the third quarter.

    While other banks have also produced disappointing third-quarter reports, Bank of America is seen as a predictor of the health of the US banking industry because it does business in widespread regions of the country.

    The Dow Jones Industrial Average was 0.22 percent lower to 13,861.81, while the Nasdaq Composite dropped 0.35 percent to 2,782.82 and the S&P 500 was down 0.38 percent to 1,535.35.

    Bank of America was $1.69 lower to $48.33 after its report.

    Elsewhere in the sector, Citigroup (NYSE: C) fell 66 cents to $44. JPMorgan Chase (NYSE: JPM; TYO: 8634), which issued a better than anticipated report on Wednesday, was still down 66 cents to $45.71.

    Wells Fargo (NYSE: WFC) dropped 80 cents to $33.49, while Wachovia (NYSE: WB) was 81 cents lower to $47.72.

    Savings and loan Washington Mutual (NYSE: WM) was $2.83 lower to $30.24 after it issued a quarterly report showing profits down by 72 percent.

    Sagging profits were not just a problem in the banking sector, however.

    Candy maker Hershey Co. (NYSE: HSY) dropped $1.51 to $42.78 after it reported that profits were down 66 percent in the quarter on poor sales and higher promotional costs.

    In the pharmaceuticals sector, meanwhile, Pfizer (NYSE: PFE) added 8 cents to $24.63 even though it reported that profits were down in its third quarter on lower sales and a charge to end investment in an inhaled form of insulin.





    August 17, 2007

    Wall Street up after Fed cuts discount rate

    Filed under: DR Horton, Administaff, Pfizer, Citigroup, Bank of America, Verizon, Qwest Communications, Sprint Nextel, Goldman Sachs, Merck, Alcatel-Lucent, Countrywide Financial, Bristol-Myers Squibb

    At just before 2 pm in New York, Wall Street was in positive territory for the day, helped by the Fed‘s cut in the discount rate.

    Most analysts now expect that the Fed will cut the benchmark interest rate when it meets in September, while some investors hope they do it even sooner than that.

    Some analysts said that if the cut in the discount rate returns confidence to the markets, the Fed might not need to cut the benchmark rate, but the Fed’s move on the discount rate was seen as evidence that the Fed is prepared to act if the markets don’t become more stable soon.

    The Dow Jones Industrial Average was 1.25 percent higher to 13,006.49, while the Nasdaq Composite had added 1.67 percent to 2,491.92 and the S&P 500 was up 1.88 percent to 1,437.77.

    Mortgage lender Countrywide Financial (NYSE: CFC), which saw big declines on Thursday after drawing down a multi-billion dollar credit line to be able to stay in operation, was up $2.23 in afternoon trade on Friday to $21.18.

    Banks were also higher.

    Citigroup (NYSE: C) had gained $1.57 to $49.12, while Bank of America (NYSE: BAC) added $1.88 to $51.73 and Goldman Sachs (NYSE: GS) was $3.98 higher to $173.83.

    Housebuilder DR Horton (NYSE: DHI) was also higher, adding 63 cents to $16.54 after Thursday’s data on new home construction came in lower than expected for July.

    The telecommunications sector was mixed. Verizon Communications (NYSE: VZ) was 11 cents higher to $40.34 and Qwest Communications (NYSE: Q) had gained 22 cents to $8.94, but Sprint-Nextel (NSYE: S) was trading even at $18.20 and Alcatel-Lucent (NYSE: ALU) had dropped 6 cents to $10.53.

    Results were also mixed in the pharmaceuticals sector.

    Pfizer (NYSE: PFE) was 53 cents higher to $23.92, but Merck (NYSE: MRK) was down 11 cents to $49.35 while Bristol-Myers Squibb had dropped 27 cents to $27.10.





    August 15, 2007

    Countrywide Financial lower on broker downgrade

    Filed under: Wal-Mart, Home Depot, Administaff, Pfizer, Merrill Lynch, Citigroup, Bank of America, Lehman Brothers, Goldman Sachs, JP Morgan, Countrywide Financial, Schering-Plough

    Wall Street saw gains in early afternoon trade on Wednesday.

    The Dow Jones Industrial Average was 0.5 percent higher to 13,094.52, while the Nasdaq Composite had added 0.65 percent to 2,515.45 and the S&P 500 was up 0.75 percent to 1,437.19.

    In the financial services sector, it was reported that Bank of America (NYSE: BAC) and Countrywide Financial (NYSE: CFC) have both refused to lend money when hedge funds use subprime securities, collateralized debt obligations or mortgages as collateral.

    Bank of America was $1.05 higher to $48.91, but Countrywide had dropped $1.96 to $22.50 after Merrill Lynch (NYSE: MER; TYO: 8675) cut its recommendation on the mortgage lender from “buy” to “sell” on worries about liquidity in the sector.

    Elsewhere among financial groups Lehman Brothers (NYSE: LEH) added 17 cents to $53.84, while Merrill Lynch gained 25 cents to $27.59 and JP Morgan Chase (NYSE: JPM) was 50 cents higher to $43.80.

    Citigroup (NYSE: C) added 57 cents to $46.23, while Goldman Sachs (NYSE: GS) was up 64 cents to $170.39.

    The pharmaceuticals sector was also higher, with Pfizer (NYSE: PFE) adding 25 cents to $23.83 and Schering-Plough (NYSE: SGP) up $1.29 to $29.60.

    Among retailers, Wal-Mart (NYSE: WMT) gained 3 cents to $43.63 and Home Depot (NYSE: HD) added 27 cents to $33.79.





    August 6, 2007

    Pharma sector higher after Merck upgrade

    Filed under: Wal-Mart, Administaff, Pfizer, Merrill Lynch, Bear Stearns, Citigroup, Bank of America, Wells Fargo, JP Morgan, Merck, Countrywide Financial, Bristol-Myers Squibb, American Home Mortgage Investments

    Wall Street was higher in early afternoon trade Monday.

    The Dow Jones Industrial Average had added 0.63 percent to 13,264.5, while the Nasdaq Composite was 0.29 percent higher to 2,518.56 and the S&P 400 was up 0.69 percent to 1,442.9.

    The Russell 2000 index had gained 0.06 percent to 755.84.

    Trade in shares of American Home Mortgage (NYSE: AHM) were halted after it had lost most of its market capitalization in the past few sessions, laid off nearly all its employees last Friday and today filed for bankruptcy protection in Delaware.

    Elsewhere in the sector, however, Countrywide Financial (NYSE: CFC) added 47 cents to $25.48.

    Investment banker Bear Stearns (NYSE: BSC) dropped $3.32 to $105.03 in the wake of last week’s reduced ratings outlook from Standard & Poor’s and after it fired an executive over the weekend.

    On the other hand, other members of the financial services sector were higher.

    Bank of America (NYSE: BAC) was 35 cents higher to $47.35, while JP Morgan Chase (NYSE: JPM) added 65 cents to $44.30, Citigroup (NYSE: C) gained 82 cents to $46.54, Wells Fargo (NYSE: WFC) was up $1.42 to $34.23 and Merrill Lynch (NYSE: MER) added $2.02 to $72.07.

    There were also gains in the pharmaceuticals sector, where Bristol-Myers Squibb (NYSE: BMY) was 7 cents higher to $28.07, Pfizer (NYSE: PFE) gained 39 cents to $23.90 and Merck (NYSE: MRK) was 80 cents higher to $51.09.

    Merck’s gains came on a broker upgrade.

    In the retail sector, Wal-Mart (NYSE: WMT) added $1.03 to $46.55 after it said that it is putting together a joint business-to-business venture in India.





    July 27, 2007

    Pharma lower ahead of GlaxoSmithKline/FDA meeting

    Filed under: Chevron, ExxonMobil, Administaff, Pfizer, Merck, GlaxoSmithKline, Crocs Inc

    In New York on Friday the Dow Jones Industrial Average was down again by more than 100 points in midday trade, falling 0.96 percent to 13,344.56, while the Nasdaq Composite had dropped 0.89 percent to 2,576.32 and the S&P 500 was 1.12 percent lower to 1,466.1.

    The declines came even though the Commerce Department had released a report calling the US economy strong in the second quarter, with the GDP up at an annual rate of 3.4 percent, better than the 3.3 percent growth that had been expected.

    A gain to 90.4 by the Reuters/University of Michigan consumer sentiment index in July didn’t seem to impress investors, either.

    The oil sector was lower after Thursday’s quarterly report from ExxonMobil (NSYE: XOM), which showed profits off from predictions.

    ExxonMobil dropped 2.2 percent to $86.24.

    Chevron, which reported profits up in the most recent quarter, was also lower, falling 2.5 percent to $85.31.

    In the pharmaceuticals sector, GlaxoSmithKline (NYSE: GSK; LSE: GSK) was down 2.79 percent to $49.80 ahead of a Monday meeting with the US Food and Drug Administration to look at the safety of its Avandia diabetes drug, which has been implicated in increased risks of heart problems to patients.

    GlaxoSmithKline claims that Avandia is as safe as other diabetes drugs and that the study which found the risks was flawed.

    Elsewhere in the sector, Pfizer (NYSE: PFE) had dropped 0.41 percent to $24.05 while Merck (NYSE: MRK) was 2.69 percent lower to $50.57.

    On the other hand, shoe manufacturer Crocs Inc (NAS: CROX) hit a new record high share prices when it went as high as $59.71 before falling back to $55.25 in midday trade, a gain of 9.2 percent on its report that earnings tripled in the second quarter and on an increased full-year forecast.





    July 23, 2007

    Merck gains on quarterly earnings increase

    Filed under: Administaff, Pfizer, Merck, American Express, Bristol-Myers Squibb, Schering-Plough, United Rentals, GlobalSantaFe Corp, Transocean Inc

    Wall Street was higher in midday trade on Monday as quarterly reports and mergers and acquisition news were in focus.

    The Dow Jones Industrial Average was 0.81 percent higher to 13,963.34, while the Nasdaq Composite had added 0.54 percent to 2,702.01 and the S&P 500 gained 0.76 percent to 1,545.79.

    The Russell 3000 index of small and mid-caps was up 0.52 percent to 840.82.

    Credit card provider American Express (NYSE: AXP) was 35 cents higher to $64.86 ahead of the release of its second quarter report, due after the close of trade on the day.

    In the pharmaceuticals sector, Merck (NYSE: MRK) said that it had seen its earnings increase by 12 percent in the quarter, sending it $3.90 higher to $52.92.

    Elsewhere in the sector, Pfizer (NYSE: PFE) gained 33 cents to $25.23 and Bristol-Myers Squibb (NSYE: BMY) added 60 cents to $32.14, but Schering-Plough (NYSE: SGP) dropped 12 cents to $31.37.

    In purchase news, offshore drilling contractor Transocean Inc. (NYSE: RIG) and GlobalSantaFe Corp. (NYSE: GSF) announced that they have made a deal to merge.

    Transocean was $6.28 higher to $116.25, while GlobalSantaFe gained $3.86 to $78.60.

    The company created by the deal will carry a market value of around $53 billion.

    In another deal, United Rentals (NYSE: URI) has agreed to be taken private by affiliates of Cereberus Capital Management in a cash deal worth $4 billion.

    Shares in United Rentals were trading $33.08 at mid-session, up 71 cents.





    July 18, 2007

    Goldman Sachs drops over $6 on sector downgrade

    Filed under: Administaff, Pulte Homes, Pfizer, Merrill Lynch, Bear Stearns, Intel, Yahoo, Lehman Brothers, Goldman Sachs, Morgan Stanley

    Wall Street was lower in early afternoon trade on Wednesday after Federal Reserve chairman Ben Bernanke made worrying remarks in testimony before Congress and as brokerages took losses after a downgrade of the biggest names in the sector.

    The Dow Jones Industrial Average was 0.72 percent lower to 13,871, while the Nasdaq Composite dropped 1.02 percent and the S&P 500 fell 0.65 percent to 1,539.34.

    An analyst at Punk Ziegel & Co downgraded the top five brokerages from “market perform” to “sell” after Bear Stearns (NYSE: BSC) said that two of its hedge funds holding subprime mortgage assets have lost almost everything.

    Bear Stearns dropped $2.12 to $137.79, while Lehman Brothers (NYSE: LEH) was 2.31 percent lower to $70.75, Morgan Stanley (NYSE: MS) fell $2.71 to $70.14, Merrill Lynch (NYSE: MER: TYO: 8675) was down $3.30 to $82.90, and Goldman Sachs (NYSE: GS) fell $6.55 to $212.85.

    Meanwhile, Mr. Bernanke’s comments in his testimony before Congress were full of concern about inflation and the state of the housing market, culminating in a lower forecast for US economic growth this year and next.

    Among housebuilders, Pulte Homes (NYSE: PHM) dropped 3.8 percent to $21.85 after it predicted losses in the second quarter.

    In the pharmaceuticals sector, Pfizer (NYSE: PFE) was 4.6 percent lower to $24.78 after both earnings and revenues were lower than had been anticipated.

    In the internet sector, Yahoo (NAS: YHOO) was down $1.37 to $26.16 after its second quarter results were about as expected but it lowered its guidance for the third quarter.

    Intel (NAS: INTC; SEHK: 4335) dropped $1.32 to $25.01 even though quarterly earnings were better than had been anticipated but gross margins were reported to have dropped.





    July 6, 2007

    US retailers see gains

    Filed under: Wal-Mart, Home Depot, Administaff, Pfizer, Merck, Target, Advanced Medical Optics, Bausch & Lomb, Schering-Plough, Macy's

    In early afternoon trade on Wall Street on Friday, the Dow Jones Industrial Average was 0.18 percent higher to 13,590.44, while the Nasdaq Composite had gained 0.09 percent to 2,659.17 and the S&P 500 was up 0.07 percent to 1,526.53.

    The news that Advanced Medical Optics (NYSE: EYE) had bid more than private equity for rival eye-care products group Bausch & Lomb (NYSE: BOL) sent shares in both lower.

    Advanced Medical Optics dropped 96 cents to $34.93, while Bausch & Lomb was down 16 cents to $71.84.

    The pharmaceuticals sector declined on the session.

    Schering-Plough (NYSE: SGP) dropped 2 cents to $30.55, while Pfizer (NYSE: PFE) fell 13 cents to $25.77 and Merck was 61 cents lower to $49.21.

    Retailers were higher, however.

    Discount retailer Wal-Mart (NYSE: WMT) added 25 cents to $48.34, while home improvement retailer Home Depot (NYSE: HD) gained 50 cents to $40.33. Macy’s (NYSE: M) was $1.75 higher to $41.52 and Target (NYSE: TGT) was up $2.67 to $66.88.





    January 24, 2007

    Nasdaq up more than 1 percent

    Filed under: ExxonMobil, Administaff, Pfizer, Advanced Micro Device, Yahoo, Sun Microsystems, Archer Daniels Midland, Aetna, Xethanol Corp

    Wall Street was up at midday on Wednesday, with the Dow Jones Industrial Average 0.32 percent higher to 12,573.46, the Nasdaq Composite up 1.09 percent to 2,457.80, and the S&P 500 adding 0.41 percent to 1,433.79. Positive earnings reports from both Yahoo and Sun Microsystems helped the gains, while the previous evening’s State of the Union address from President George W. Bush didn’t seem to have much impact at all on investors’ activities.

    After Mr. Bush proposed an expansion in health care coverage in the speech last night, health benefits insurer Aetna dropped 47 cents to $41.71. In a related sector, drug maker Pfizer added 22 cents to $26.59.

    ExxonMobil dropped 22 cents to $74.26 after an announcement of higher crude oil, gasoline, and distillate inventories again last week. Alternative energy producers were lower as well, after posting gains before the president’s address. Ethanol maker Xethanol Corp. dropped 17 cents to $2.90, while Archer Daniels Midland fell $1.06 to $31.57.

    Sun Microsystems added 43 cents to $6.09 after increased revenues gave the manufacturer of server and storage products its first quarterly profit in several years. Meanwhile, Yahoo gained $2.03 to $28.99 on fourth quarter profits that were higher than had been anticipated. But Advanced Micro Devices dropped $1.39 to $16.12 reported losses in the fourth quarter, which were blamed on flat sales of server chips.





    Next Page »

    Latest Equities News:

  • Wall Street ends lower despite rate cut

  • Asia-Pacific, Europe equities see declines

  • Hang Seng adds 10.72 percent on session

  • India’s Sensex drops 1,408 points on session

  • Australian markets drop for 9th straight day

  • Taiex gains on opposition win in parliamentary elections

  • Hang Seng drops nearly 400 points

  • Most Asia-Pacific markets drop on US recession worries

  • Tokyo declines on export worries

  • Asia-Pacific equities mixed on economic concerns

  • NYSE News copyright 2005 Central Consultants